107 related articles for article (PubMed ID: 2807575)
21. Human alveolar macrophage and blood monocyte inhibition of fibroblast proliferation. Evidence for synergy between interleukin-1 and tumor necrosis factor.
Elias JA; Gustilo K; Freundlich B
Am Rev Respir Dis; 1988 Dec; 138(6):1595-603. PubMed ID: 3264485
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide.
Postlethwaite AE; Seyer JM
J Exp Med; 1990 Dec; 172(6):1749-56. PubMed ID: 2258704
[TBL] [Abstract][Full Text] [Related]
23. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
24. Modulation of monocyte antigen-presenting capacity by tumour necrosis factor-alpha (TNF): opposing effects of exogenous TNF before and after an antigen pulse and the role of TNF gene activation in monocytes.
Kowalczyk D; Mytar B; JasiĆski M; Pryjma J; Zembala M
Immunol Lett; 1995 Jan; 44(1):51-7. PubMed ID: 7721344
[TBL] [Abstract][Full Text] [Related]
25. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
Danis VA; Franic GM; Rathjen DA; Brooks PM
Clin Exp Immunol; 1991 Jul; 85(1):143-50. PubMed ID: 1906383
[TBL] [Abstract][Full Text] [Related]
26. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.
Issekutz AC; Chuluyan HE; Lopes N
J Leukoc Biol; 1995 Apr; 57(4):553-61. PubMed ID: 7722414
[TBL] [Abstract][Full Text] [Related]
27. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.
Issekutz AC; Issekutz TB
J Immunol; 1993 Aug; 151(4):2105-15. PubMed ID: 8345197
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor alpha induces migration of human eosinophils.
Nagata M; Fukuda T; Numao T; Makino S; Dohi Y
Arerugi; 1993 Apr; 42(4):549-55. PubMed ID: 8323453
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
30. Expression of IL-8 gene in human monocytes and lymphocytes: differential regulation by TNF and IL-1.
Chaly YV; Selvan RS; Fegeding KV; Kolesnikova TS; Voitenok NN
Cytokine; 2000 Jun; 12(6):636-43. PubMed ID: 10843739
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13.
Jinquan T; Frydenberg J; Mukaida N; Bonde J; Larsen CG; Matsushima K; Thestrup-Pedersen K
J Immunol; 1995 Dec; 155(11):5359-68. PubMed ID: 7594551
[TBL] [Abstract][Full Text] [Related]
32. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes.
Wang JM; Walter S; Mantovani A
Immunology; 1990 Nov; 71(3):364-7. PubMed ID: 2269474
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.
Movat HZ
J Lab Clin Med; 1987 Dec; 110(6):668-81. PubMed ID: 3316455
[No Abstract] [Full Text] [Related]
35. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha.
Ueta C; Kawasumi H; Fujiwara H; Miyagawa T; Kida H; Ohmoto Y; Kishimoto S; Tsuyuguchi I
Eur J Immunol; 1996 Dec; 26(12):3066-73. PubMed ID: 8977306
[TBL] [Abstract][Full Text] [Related]
36. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines.
Antony VB; Hott JW; Kunkel SL; Godbey SW; Burdick MD; Strieter RM
Am J Respir Cell Mol Biol; 1995 Jun; 12(6):581-8. PubMed ID: 7766422
[TBL] [Abstract][Full Text] [Related]
37. Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody.
Baj-Krzyworzeka M; Baran J; Szatanek R; Stankiewicz D; Siedlar M; Zembala M
Cancer Immun; 2004 Aug; 4():8. PubMed ID: 15327279
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
Akarasereenont P; Bakhle YS; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Jun; 115(3):401-8. PubMed ID: 7582449
[TBL] [Abstract][Full Text] [Related]
39. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
Levesque MC; Haynes BF
J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
[TBL] [Abstract][Full Text] [Related]
40. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells.
Eliassen LT; Rekdal O; Svendsen JS; Osterud B
Thromb Haemost; 2000 Apr; 83(4):598-604. PubMed ID: 10780324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]